ITRM
Iterum TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ITRM Profile
Iterum Therapeutics Plc
A clinical-stage pharmaceutical company focused on therapeutics for multi-drug rsistant pathogens
3 Dublin Landings, North Wall Quay, Dublin 1, Ireland
--
Iterum Therapeutics Plc was incorporated in Ireland on June 24, 2015. The company is a clinical-stage pharmaceutical company dedicated to the development and commercialization of sulopenem, which may be the first available oral penem in the United States and the first and only available oral and intravenous (IV) brand penem in the world. Sulopenem is a powerful, intravenously delivered antibiotic of thiopenem that is active against bacteria belonging to a group known as gram negative, causing urinary tract and intra-abdominal infections.
